The Form 4 filing for Chief Executive Officer Emily M. Leproust was filed on November 18, 2026. It covers a trade made two days earlier, on November 16. Form 4 reports changes in an insider's stock ownership.
Twist Bioscience is listed in the healthcare sector and biotechnology industry.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-16 |
| Date of Latest Transaction | 2026-11-16 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 19,045 |
| Price | $103.69 |
| Total Transaction Value | $1,974,737.96 |
| Insider | |
| Ticker Symbol | TWST |
| Company | Twist Bioscience Corp |
| Insider Name | Leproust Emily M. |
| Insider Title | Chief Executive Officer |
| Sector - Industry | Healthcare - Biotechnology |
| Holdings | |
| Total Shares Owned After Transaction | 634,493 |
| Position Size Change | 2.91% |
| Filing | |
| Filing Date | 2026-11-18 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was one sale of TWST shares, reported under transaction code S. The transaction information also identifies a link to taxes tied to stock pay.
What was the average price of the transaction?
The reported average sale price was $103.688 per share. Rounded to cents, that is $103.69.
How did this transaction affect the insider's holdings?
Emily M. Leproust sold 19,045 shares and reported 634,493 shares owned afterward. The shares sold made up 2.91% of her reported holdings before the sale.
What's the total transaction value?
The total reported sale value was $1,974,737.96. That amount covers the single transaction reported for November 16, 2026.
Are there any special circumstances around this transaction?
The sale was identified as linked to covering taxes tied to pay received in stock. No filing footnote text was provided, so the exact tax bill and sale terms are unknown. The available information also does not show whether taxes were the sale's only purpose.
For research purposes only; not investment advice.